Scott Van Winkle analyst

Currently out of the existing stock ratings of Scott Van Winkle, 5 are a BUY (50%), 5 are a HOLD (50%).

Scott Van Winkle

Work Performance Price Targets & Ratings Chart

Analyst Scott Van Winkle, carries an average stock price target met ratio of 91.67% that have a potential upside of 37.39% achieved within 568 days. Previously, Scott Van Winkle worked at CANACCORD.

Scott Van Winkle’s has documented 21 price targets and ratings displayed on 2 stocks. The coverage was on the Consumer Defensive sector.

Most recent stock forecast was given on HLF, Herbalife Nutrition Ltd at 15-Oct-2015.

Wall Street Analyst Scott Van Winkle

Analyst best performing recommendations are on HLF (HERBALIFE NUTRITION LTD).
The best stock recommendation documented was for NUS (NU SKIN ENTERPRISES) at 7/10/2013. The price target of $83 was fulfilled within 118 days with a profit of $27.96 (50.8%) receiving and performance score of 4.31.

Average potential price target upside

NUS Nu Skin Enterprises HLF Herbalife Nutrition Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$7

$-0.92 (-11.62%)

$11

2 months 11 days ago
(20-Dec-2024)

9/20 (45%)

$0.4 (6.06%)

129

Hold

$6.75

$-1.17 (-14.77%)

$18

4 months 9 days ago
(22-Oct-2024)

4/9 (44.44%)

$0.71 (11.75%)

30

Hold

$14

$6.08 (76.77%)

$75

10 months 8 days ago
(23-Apr-2024)

3/12 (25%)

$1.49 (11.91%)

206

Hold

$25

$17.08 (215.66%)

$27

1 years 4 months 1 days ago
(02-Nov-2023)

7/13 (53.85%)

$8.91 (55.38%)

145

Buy

$39

$31.08 (392.42%)

2 years 1 months ago
(31-Jan-2023)

1/1 (100%)

$-0.42 (-1.07%)

21

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Scott Van Winkle?

On 2011

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?